Xconomy San Francisco

Solazyme Raises $52 Million

Wade Roush8/9/10

The South San Francisco company that pioneered the idea of using algae to make biofuels, Solazyme, said today that it has raised $52 million in Series D financing. New investor Morgan Stanley and Braemar Energy Ventures led the round, which also included all of the company’s major existing investors—CTTV Investments, Harris and Harris Group, Lightspeed Venture Partners, the Roda Group, San-Ei Gen, VantagePoint Venture Partners, and Zygote Ventures. As Xconomy’s Luke Timmerman reported in a recent profile of Solazyme, the 90-employee company uses molecular biology techniques to engineer strains of algae that convert high-cellulose materials such as sugarcane into different varieties of oil inside large fermentation tanks.

Wade Roush is Xconomy's chief correspondent and editor of Xconomy San Francisco. You can e-mail him at wroush@xconomy.com or follow him on Twitter at twitter.com/wroush.

Related Topics

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.